---
title: "GLACIER BASIN BIOTECH FUND LLC SEC filings"
url: https://altstreet.investments/edgar/1997850
kind: edgar-entity
updated: 2026-07-31
publisher: AltStreet (https://altstreet.investments)
license: Public factual pages may be read, quoted and cited with attribution and a link. Bulk redistribution is not permitted.
---

# GLACIER BASIN BIOTECH FUND LLC: SEC filings and what they report

Glacier Basin Biotech Fund LLC is a Delaware pooled investment fund filed October 19, 2023, by executive officer Matthew McLoughlin under Rule 506(b) and Section 3(c)(1). The filing indicates pre-open status with no capital raised or investor count disclosed; minimum investment is set at $50,000. The fund targets longevity biotech investments and appears to operate independently without identified parent platforms or related entities.

| Field | Value |
| --- | --- |
| Entity | GLACIER BASIN BIOTECH FUND LLC |
| CIK | 1997850 |
| Filing family | 506(b), 3(c)(1) |
| Entity type | fund vehicle |
| Manager (as filed) | Glacier Basin |
| Platform | GLACIER BASIN BIOTECH FUND LLC (https://altstreet.investments/platforms/glacier-basin-biotech-fund-llc) |
| Newest fact-bearing filing | October 19, 2023, accession 0001997850-23-000001 |
| Total sold (as reported) | $0 |
| Investors (as reported) | 0 |
| Minimum investment (as filed) | $50,000 |
| Vintage | 2023 |

## Related persons (Form D Item 3)

| Name | Relationship |
| --- | --- |
| MATTHEW MCLOUGHLIN | Executive Officer |


## Filings (1 on record, newest first)

| Date | Form | Family | SEC link |
| --- | --- | --- | --- |
| October 19, 2023 | D | Form D | https://www.sec.gov/Archives/edgar/data/1997850/000199785023000001/ |


## More

- Entity page (HTML, with events, parties and the platform record): https://altstreet.investments/edgar/1997850
- SEC EDGAR filing index: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001997850&owner=include&count=40
- Other issuers on GLACIER BASIN BIOTECH FUND LLC: https://altstreet.investments/deals/platform/glacier-basin-biotech-fund-llc
- Signal history, evidence passages and the entity graph are AltStreet Terminal features: https://altstreet.investments/terminal

---

Source page: https://altstreet.investments/edgar/1997850
Machine index: https://altstreet.investments/llms.txt
AltStreet reads what platforms, funds and issuers file with the SEC and what they tell investors, and publishes the difference. Figures are as filed or as captured on the date stated; nothing here is investment advice.